Trial · NCT07886541
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Length of hospital stay | Within the first 30 days after chest tube insertion. | This is defined as the number of days from chest tube insertion to hospital discharge. |
| Secondary | Duration of chest tube drainage | 30 days | Number of days between chest tube insertion and removal of chest tube |
| Secondary | Delayed discharge days | 30 days | The number of hospital days between completion of treatment and actual hospital discharge that are unrelated to the treatment of the parapneumonic pleural infection (e.g. awaiting nursing home placement, rehabilitation facility placement, home care arrangements, or other administrative or logistical delays). |
| Secondary | Re-intervention rates | 30 days | The need for additional drainage procedures or surgery |
| Secondary | Re-admission rates | 30 days | Need for re-admission |
| Secondary | Morbidity | 30 days | Defined as any deviation from the expected clinical course, including complications and (serious) adverse events |
| Secondary | Mortality | 30-day and 1-year mortality | Mortality (30-day and 1-year) |
| Secondary | Type of antibiotic therapy | Up to 3 months after initiation of antibiotic therapy | Type of antibiotic therapy |
| Secondary | Duration of antibiotic therapy | Up to 3 months after initiation of antibiotic therapy | Duration of antibiotic therapy (in days) |
| Secondary | Type of analgesic use | 30 days | Type of analgesic use |
| Secondary | Duration of analgesic use | 30 days | Duration of analgesic use (in days) |
| Secondary | Healthcare consumption costs | Through study completion (at 1, 3, 6, 9, and 12 months after randomization) | Healthcare consumption will be assessed using the iMTA Medical Consumption Questionnaire (iMCQ), an instrument designed to measure medical consumption, including contacts with healthcare providers, hospitalizations, medical procedures, medication use, and other healthcare services. The questionnaire will be used to assess healthcare consumption following randomization. |
| Secondary | Productivity loss costs | Through study completion (at 1, 3, 6, 9, and 12 months after randomization) | Productivity losses will be assessed using the iMTA Productivity Cost Questionnaire (iPCQ), a standardized instrument for measuring productivity losses for use in economic evaluations of healthcare. The questionnaire will be used to assess productivity losses following randomization. |
| Secondary | Health-related quality of life | Through study completion (at baseline, 1 week, 2 weeks, 1, 3, 6, 9, and 12 months after randomization) | Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The questionnaire assesses five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, ranging from no problems to extreme problems. Responses will be used to assess health-related quality of life. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07886541/registered